FDA Investigator Demitria J Argiropoulos

Demitria J Argiropoulos has inspections in 1 countries as of 20 Sep 2023. Demitria J Argiropoulos has collaborated with a combinined 1681 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100001096
Country:
United States of America
Co-Investigator(s):
Alice S Tsao, Althea A Williams, Amber D Brodas, Anissa M Vargas, Ann M Stewart, Anna M Alexander, Antonina Aydanian, Bijoy Panicker, Brandy N Lepage, Charanjeet Jassal, Charisse K Green, Charles Jewell, D Jenny Argiropoulos, Demitria J Argiiropoulos, Demitria J Argiropolous, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Diane L Raccasi, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Felix Maldonado, Frank Verni, Freyja V Lynn, Gam S Zamil, Gregson A Joseph, Helen B Ricalde, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, Jane Chen, Jennifer L Bridgewater, Jogy George, Joseph J Vannelli, Joseph Milcetic, Juliana M Badalucco, Julie D Bringger, Karen L Kosar, Kevin A Gonzalez, Kristina L Conroy, Kwong P Lee, Lata C Mathew, PhD, Leena Thomas, Lori P Peters, Manhar R Patel, Margaret E Sarles, Maria Joselopez Barragan, PhD, Marie Elena C Puleo, Marjorie A Shapiro, PhD, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew A Spataro, Michael Levin, Mihaly S Ligmond, Milan S Blake, Mindy M Chou, Nancy T Waites, Omotunde O Osunsanmi, Parul M Patel, Paul E Stein, Paul Mouris, Paula A Trost, Perry T Nichols, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachael O Oyewole, Richard W Thornton, Robert C Steyert, Robert Jennings, Robert W Jennings, Ruben C Quintana, Samina S Khan, Samuel T Walker, Sarah B Tanksley, Satheesh Thomas, Scott E Norris, Shari L Kahn, Simone E Pitts, Sony Mathews, Stella Yuen, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tej Poonai, Tina S Roecklein, Unnee Ranjan, Vivin George, Wayne E Seifert, Yvins Dezan

Demitria J Argiropoulos's Documents

Publish Date Document Type Title
July, 2004 EIR Nepera, a Division of Rutherford Chemicals LLC - EIR, 2004-07-30
March, 2008 FDA 483 Premier Brands of America Inc - Form 483, 2008-03-17
April, 2006 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2006-04-13
January, 2004 EIR Breonics, Inc. - EIR, 2004-01-14
November, 2008 FDA 483 Watson Laboratories, Inc. - Form 483, 2008-11-26
September, 2003 EIR Avon Products Inc - EIR, 2003-09-26
July, 2005 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2005-07-25
July, 2002 EIR Auxilium Pharmaceuticals, LLC - EIR, 2002-07-01
October, 2009 FDA 483 SML Acquisition, LLC (aka San-mar Laboratories, Inc) - Form 483, 2009-10-20
July, 2004 FDA 483 Response Nepera, a Division of Rutherford Chemicals LLC - Form 483R, 2004-08-24
February, 2010 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2010-02-09
February, 2009 FDA 483 Ultra Seal Corporation - Form 483, 2009-02-11
August, 2008 FDA 483 Professional Disposables International, Inc. - Form 483, 2008-08-12
May, 2010 FDA 483 Response ULTRAtab Laboratories, Inc. - Form 483R, 2010-06-15
August, 2008 FDA 483 RIJ Pharmaceutical LLC - Form 483, 2008-08-04
March, 2004 FDA 483 Response Ultra Seal Corporation - Form 483R, 2004-04-06
November, 2008 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2008-11-03
May, 2010 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2010-05-05
October, 2006 FDA 483 Premier Brands of America Inc - Form 483, 2006-10-27
March, 2004 FDA 483 Ultra Seal Corporation - Form 483, 2004-03-08
July, 2006 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2006-07-11
June, 2006 FDA 483 International Pharmaceuticals & Biotechnology Laboratories - Form 483, 2006-06-01
July, 2004 FDA 483 Nepera, a Division of Rutherford Chemicals LLC - Form 483, 2004-07-30
August, 2006 FDA 483 Perrigo New York, Inc. - Form 483, 2006-08-31
March, 2008 FDA 483 Avon Products Inc - Form 483, 2008-03-03
May, 2009 FDA 483 Taro Pharmaceuticals U.S.A., Inc. - Form 483, 2009-05-29

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more